Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5H95B | — |
Administration of Kinrix to a 2 month patient; Administration of Kinrix to a 2 month patient and the intended vaccine was Infanrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis. On 19-JUN-2025, the patient received the 1st dose of Kinrix. On an unknown date, the patient did not receive Infanrix. On 19-JUN-2025, an unknown time after receiving Kinrix and not applicable after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration of Kinrix to a 2 month patient) and wrong vaccine administered (Verbatim: Administration of Kinrix to a 2 month patient and the intended vaccine was Infanrix). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-JUN-2025 The patient's age was 2 months and 23 days old. The nurse reported that last week, they had a child patient, and they got Kinrix, which was not recommended until 4 to 6 years old and HCP mentioned that the intended vaccine was Infanrix, it was given by mistake, which led to inappropriate age at vaccine administration and wrong vaccine administered The Vaccine Administration Facility is the same as Primary Reporter.